News | March 20, 2025
Briefs: Dr. Agarwal's Eye Hospital and Apitoria Pharma
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The European regulator will conduct a re-inspection of the facility to verify the compliance
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
The observations issued are neither repeated observations nor related to data integrity
The Alathur facility specializes in the production of Cephalosporin antibiotics
Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one year
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
Subscribe To Our Newsletter & Stay Updated
